BEHAV3D: an imaging and transcriptomics platform that unravels T cell antitumor activity
- PMID: 35902779
- DOI: 10.1038/s41587-022-01398-9
BEHAV3D: an imaging and transcriptomics platform that unravels T cell antitumor activity
Comment on
-
Uncovering the mode of action of engineered T cells in patient cancer organoids.Nat Biotechnol. 2023 Jan;41(1):60-69. doi: 10.1038/s41587-022-01397-w. Epub 2022 Jul 25. Nat Biotechnol. 2023. PMID: 35879361 Free PMC article.
References
-
- Chen, D. S. & Mellman, I. Elements of cancer immunity and the cancer-immune set point. Nature 541, 321–330 (2017). A report on the limitations of immunotherapy for solid tumors. - DOI
-
- Hegde, P. S. & Chen, D. S. Top 10 challenges in cancer immunotherapy. Immunity 52, 17–35 (2019). A Perspective article that presents the current challenges in optimization of cancer immunotherapy. - DOI
-
- Tuveson, D. & Clevers, H. Cancer modeling meets human organoid technology. Science 364, 952–955 (2019). A Review discussing the use of organoids as tumor models that recapitulate the original tumor characteristics. - DOI
-
- Ganesh, K. et al. A rectal cancer organoid platform to study individual responses to chemoradiation. Nat. Med. 25, 1607–1614 (2019). A research article showing the potential of organoids for personalized treatment. - DOI
-
- Crainiciuc, G. et al. Behavioural immune landscapes of inflammation. Nature 601, 415–421 (2022). A research article that demonstrates how behavioral profiling can be used to infer immune cell function. - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
